Robert Steiner
Josip Juraj Strossmayer University of Osijek
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Robert Steiner.
Journal of Cardiology Cases | 2013
Ivica Bošnjak; Kristina Selthofer-Relatić; Vlatka Periša; Robert Steiner
Essential thrombocythemia (ET), a chronic myeloproliferative disease, is characterized by an increased number of platelets and risk of vascular thrombosis. A case of a patient treated for ET who had acute myocardial infarction (MI) and reinfarction within a month is presented. A 55-year-old male patient was hospitalized because of subacute inferolateral non-ST-segment-elevation MI, without risk factors for cardiovascular diseases. The patient has been treated for ET for the past 8 years, received anagrelide for the past two years. The first coronary-angiography did not detect significant stenosis of epicardial vessels; the patient was discharged in stable condition with anagrelide therapy. Two weeks later, the patient had an acute anterolateral ST-segment-elevation MI. Primary percutaneous coronary intervention showed thrombus in the distal part of the left anterior descending coronary artery. Percutaneous transluminal coronary angioplasty was performed and eptifibatide was administered after the procedure. There was no residual stenosis, prescribed therapy included clopidogrel and low-molecular-weight heparin. Anagrelide therapy was replaced with hydroxyurea (HU) and acetylsalicylic acid (ASA). It is necessary to treat ET in line with the standard treatment protocol for coronary diseases. In the treatment of high-risk hematology patients anagrelide proved to be a worse option than the combination of HU and ASA. <Learning objective: It is known that the myeloproliferative disorders carry the risk of vascular thrombosis and myocardial infarction. The occurrence of vascular events is usually the first sign of the disease. A case of a patient with history of hematological disease, who was receiving active treatment and was well-regulated with oral medication, is presented here. Various approaches to treatment of such patients are possible and treatment decision-making is important for clinicians. Therefore, this article presents both our view on this issue and an overview of the literature in this area.>.
Collegium Antropologicum | 2015
Sandra Makarović; Zorin Makarović; Robert Steiner; Ivan Mihaljević; Jasminka Milas-Ahić
Collegium Antropologicum | 2003
Goran Miličević; Nina Smolej Narančić; Robert Steiner; Pavao Rudan
Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina | 2012
Kristina Selthofer-Relatić; Dalibor Divković; Radivoje Radić; Vedrana Vizjak; Robert Selthofer; Robert Steiner; Ivica Bošnjak
Collegium Antropologicum | 2011
Kristina Selthofer-Relatić; Radivoje Radić; Aleksandar Včev; Robert Steiner; Vedrana Vizjak; Miroslav Šrama; Marija Tripolskia; Pašezada Kosović; Ivica Bošnjak; Robert Selthofer
Collegium Antropologicum | 2014
Robert Steiner; Sandra Makarović; Zorin Makarović; Ines Bilic-Curcic
Cardiologia Croatica | 2016
Zorin Makarović; Sandra Makarović; Damir Kirner; Robert Steiner; Ivica Bošnjak; Marin Vuckovic; Dragan Novosel; Drazen Mlinarevic
XXI World Congress of Echocardiography and Cardiology | 2015
Vedrana Baraban; Livija Sušić; Josip Vincelj; Robert Steiner
Criminology | 2015
Lana Maričić; Sandra Makarović; Kristina Selthofer-Relatić; Krešimir Jelić; Robert Steiner
European Congress on e-Cardiology & e-Health, Book of Abstracts | 2014
Vedrana Baraban; Srđan Čalošević; Sven Kurbel; Robert Steiner; Svjetlana Marić